RVMD
Price:
$47.29
Market Cap:
$8.62B
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RA...[Read more]
Industry
Biotechnology
IPO Date
2020-02-13
Stock Exchange
NASDAQ
Ticker
RVMD
According to Revolution Medicines, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.24. This represents a change of -6.88% compared to the average of 15.30 of the last 4 quarters.
The mean historical Current Ratio of Revolution Medicines, Inc. over the last ten years is 10.14. The current 14.24 Current Ratio has changed 13.95% with respect to the historical average. Over the past ten years (40 quarters), RVMD's Current Ratio was at its highest in in the December 2021 quarter at 30.48. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
10.14
Median
9.63
Minimum
1.24
Maximum
30.48
Discovering the peaks and valleys of Revolution Medicines, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 216.66%
Maximum Annual Current Ratio = 30.48
Minimum Annual Increase = -65.06%
Minimum Annual Current Ratio = 1.24
Year | Current Ratio | Change |
---|---|---|
2023 | 13.06 | 22.66% |
2022 | 10.65 | -65.06% |
2021 | 30.48 | 216.66% |
2020 | 9.63 | 209.32% |
2019 | 3.11 | 11.29% |
2018 | 2.80 | 125.04% |
The current Current Ratio of Revolution Medicines, Inc. (RVMD) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
18.07
5-year avg
13.39
10-year avg
10.14
Revolution Medicines, Inc.’s Current Ratio is greater than Blueprint Medicines Corporation (3.32), greater than Sana Biotechnology, Inc. (4.47), greater than Kymera Therapeutics, Inc. (8.55), greater than Monte Rosa Therapeutics, Inc. (6.03), greater than TCR2 Therapeutics Inc. (2.77), greater than Black Diamond Therapeutics, Inc. (5.55), greater than Atreca, Inc. (1.58), greater than Passage Bio, Inc. (5.15), less than Akero Therapeutics, Inc. (17.25), less than Avidity Biosciences, Inc. (17.76), greater than Protagonist Therapeutics, Inc. (10.70), greater than Stoke Therapeutics, Inc. (5.09), greater than Homology Medicines, Inc. (4.19), greater than C4 Therapeutics, Inc. (6.31), greater than Agios Pharmaceuticals, Inc. (8.99), greater than Nurix Therapeutics, Inc. (5.28),
Company | Current Ratio | Market cap |
---|---|---|
3.32 | $6.06B | |
4.47 | $553.71M | |
8.55 | $2.92B | |
6.03 | $579.96M | |
2.77 | $58.11M | |
5.55 | $138.07M | |
1.58 | $3.57M | |
5.15 | $48.95M | |
17.25 | $2.14B | |
17.76 | $4.31B | |
10.70 | $2.48B | |
5.09 | $702.34M | |
4.19 | $3.02M | |
6.31 | $304.24M | |
8.99 | $2.62B | |
5.28 | $1.56B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revolution Medicines, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Revolution Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Revolution Medicines, Inc.'s Current Ratio?
How is the Current Ratio calculated for Revolution Medicines, Inc. (RVMD)?
What is the highest Current Ratio for Revolution Medicines, Inc. (RVMD)?
What is the 3-year average Current Ratio for Revolution Medicines, Inc. (RVMD)?
What is the 5-year average Current Ratio for Revolution Medicines, Inc. (RVMD)?
How does the current Current Ratio for Revolution Medicines, Inc. (RVMD) compare to its historical average?